Economic analysis of a phase III clinical trial evaluating the addition of total androgen suppression to radiation versus radiation alone for locally advanced prostate cancer (Radiation Therapy Oncology Group protocol 86-10)-Reference-Cited by-同舟云学术

Economic analysis of a phase III clinical trial evaluating the addition of total androgen suppression to radiation versus radiation alone for locally advanced prostate cancer (Radiation Therapy Oncology Group protocol 86-10)

Published:2005-11 Issue:3 Volume:63 Page:788-794
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Konski Andre,Sherman Eric,Krahn Murray,Bremner Karen,Beck J. Robert,Watkins-Bruner Deborah,Pilepich Michael

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference23 articles.

1. Effect of a short course of neoadjuvant hormonal therapy on the response to subsequent androgen suppression in prostate cancer patients with relapse after radiotherapy;Shipley;Int J Radiat Oncol Biol Phys,2002

2. Subset analysis of RTOG 85-31 and 86-10 indicates an advantage for long-term vs. short-term adjuvant hormones for patients with locally advanced nonmetastatic prostate cancer treated with radiation therapy;Horwitz;Int J Radiat Oncol Biol Phys,2001

3. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin;Bolla;N Engl J Med,1997

4. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma;Pilepich;Urology,1995

5. Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy;Pilepich;J Clin Oncol,1997

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. When Patience is a Failing: The Case for Patient Reported Outcomes Adoption;International Journal of Radiation Oncology*Biology*Physics;2023-07

2. Systematic Review of Cost-Effectiveness Models in Prostate Cancer: Exploring New Developments in Testing and Diagnosis;Value in Health;2022-01

3. Are Medical Care Prices Still Declining? A Re‐Examination Based on Cost‐Effectiveness Studies;Econometrica;2022

4. Prostate cancer mortality and metastasis under different biopsy frequencies in North American active surveillance cohorts;Cancer;2019-10-22

5. Early versus deferred standard androgen suppression therapy for advanced hormone-sensitive prostate cancer;Cochrane Database of Systematic Reviews;2019-06-11